While the tech firms are not immune to the current turbulent operating environment, they have the ability to modify the current weakness and drive new demand post the pandemic. Semiconductor stocks were one of the best performing stocks this year despite the pandemic situation and the mounting tensions between the US and China. The PHLX Semiconductor Sector Index (SOX), which contains the top 30 chip companies, rose 60% from the low levels it hit during March. Let’s look whether semiconductor manufacturer Texas Instruments (NASDAQ: TXN) is a good choice to buy.
Overview
Texas Instruments (TI) makes and sells semiconductors to the industrial and automotive markets. The 90-year old firm operates with three segments; Analog, Embedded Processing and Other. Sales of Analog products generated about 71% of TI’s revenue in 2019. Analog products are used in many markets, particularly industrial, automotive and personal electronics. Embedded Processing products are used in industrial and automotive markets. The company reports the results of other business activities in the Other segment. TI markets and sells its products through direct sales channels. In 2019, about 65% of the sales were fulfilled through distributors. As of December 31, 2019, Texas had 29,768 employees.
2019 performance
For the fiscal year ended December 31, 2019, TI’s revenue declined 9% to $14.38 billion, primarily due to lower revenue from Analog and Embedded Processing segments. Earnings dropped to $5.02 billion or $5.24 per share in 2019 from $5.58 billion or $5.59 per share in the prior year. Revenue from Analog, Embedded Processing and Other businesses, decreased 5%, 17%, and 15%, respectively.
[irp posts=”57408″]
COVID-19 impact
As a result of the pandemic, TI reported a 7% year-over-year drop in revenue and EPS declined 2% in the recently ended first quarter. During the first quarter earnings call, the company pointed out how it bounced back from the 2008 recession. Using the 2008 financial crisis as a model and with the reduced visibility in customer demand, TI expanded the guidance range for its second quarter of 2020.
Competition
TI competes fiercely with other large and small companies, including both broad-based suppliers and niche suppliers all over the world. Competitors also include emerging companies, particularly in Asia, that sell products into the same markets in which it operates. Recently, rival Analog Devices (NASDAQ: ADI) acquired Maxim Integrated Products (NASDAQ: MXIM) in a $21 billion transaction. This merger would create a stronger Number 2 player in the non-customized analog chip market behind TI.
What’s next?
TXN stock reached its 52-week high ($135.70) in January this year. Hurt by the COVID-19 related recession, shares of TI plummeted to yearly low in March. However, it bounced back and is currently trading near the 52-week high mark. The Dallas, Texas-based company is expected to announce its Q2 financial results on July 21.
[irp posts=”57628″]
There is no doubt that TI will continue to face the pressure for the rest of the year, but it has got enough strength to handle these turbulent times. TI’s strong cash flow generation of $5.64 billion in trailing 12 months, a shareholder return of $2.5 billion in the second quarter ($841 million in dividends and $1.6 billion in stock repurchase) and $4.74 billion of cash at March end shows how profitable the company is in this volatile environment. Like how TI bounced back from the 2008 financial crisis, it is expected to perform better once the current dust settles down. Since the digital based businesses are here to stay, TXN will be a worthy semiconductor stock to have in your portfolio.
DISCLAIMER: This article does not necessarily imply the views of AlphaStreet, and contains opinions of the author alone.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on